Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-21-069425

See Remarks acquired 25,311 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
McNeill Jonathan See Remarks 2021-12-10 Grant or award +25,311 60,947 D
Derivatives
McNeill Jonathan See Remarks 2021-12-10 Grant or award · Stock Option (right to buy) +37,967 37,967 D
Loading xslF345X03/doc4.xml…